Xencor (XNCR) Net Cash Flow (2013 - 2026)
Xencor's (XNCR) quarterly Net Cash Flow came in at -$40.0 million in Q1 2026, down 2969.92% year-on-year from $1.4 million in Q1 2025, and down 255.14% on a QoQ basis from $25.8 million in Q4 2025.
Xencor (XNCR) Net Cash Flow (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Net Cash Flow data on file, last reported at -$40.0 million in Q1 2026.
- On a quarterly basis, Net Cash Flow fell 2969.92% year-over-year to -$40.0 million in Q1 2026; TTM through Mar 2026 was -$25.6 million, a 399.64% decrease from a year earlier, with the FY2025 full-year figure at $13.1 million, up 201.49% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$40.0 million, down from $25.8 million in the prior quarter.
- Over the last five years, Net Cash Flow for XNCR reached as high as $25.8 million in Q4 2025 and fell as low as -$65.2 million in Q1 2022.
- Historically, Net Cash Flow has averaged -$7.6 million across 5 years, with a median of -$264000.0 in 2024.
- Across the five-year window, Net Cash Flow jumped 1906.44% in 2025 and plunged 2969.92% in 2026, its largest moves.
- Year by year, Net Cash Flow stood at $1.3 million in 2022, then retreated by 17.78% to $1.1 million in 2023, then soared by 1018.6% to $11.8 million in 2024, then surged by 117.65% to $25.8 million in 2025, then slumped by 255.14% to -$40.0 million in 2026.
- Per Business Quant data, the three most recent Net Cash Flow figures were -$40.0 million in Q1 2026, $25.8 million in Q4 2025, and -$16.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | -40.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.00 Mn |
| Mar 31, 2026 | -40.00 Mn |
| Dec 31, 2025 | 25.78 Mn |
| Dec 31, 2025 | 25.78 Mn |
| Sep 30, 2025 | -16.15 Mn |
| Sep 30, 2025 | -16.15 Mn |
| Jun 30, 2025 | 4.77 Mn |
| Jun 30, 2025 | 4.77 Mn |
| Mar 31, 2025 | -1.30 Mn |
| Mar 31, 2025 | -1.30 Mn |
| Dec 31, 2024 | 11.85 Mn |
| Dec 31, 2024 | 11.85 Mn |
| Sep 30, 2024 | -1.74 Mn |
| Sep 30, 2024 | -1.74 Mn |
| Jun 30, 2024 | -264,000.00 |
| Jun 30, 2024 | -264,000.00 |
| Mar 31, 2024 | -22.75 Mn |
| Mar 31, 2024 | -22.75 Mn |
| Dec 31, 2023 | 1.06 Mn |
| Dec 31, 2023 | 1.06 Mn |